PGP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PGP Antibodies for the specific detection and analysis of P-glycoprotein (PGP). PGP Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). P-glycoprotein functions as a drug efflux pump in cell membranes, playing a significant role in multidrug resistance in cancer cells and influencing pharmacokinetics of therapeutic agents. Understanding P-glycoprotein expression and function is essential for developing effective cancer treatments and improving drug delivery systems. Researchers studying P-glycoprotein can explore its role in various cellular processes and drug resistance mechanisms. Advanced research in P-glycoprotein has revealed its importance in protecting cells from harmful substances and maintaining cellular homeostasis. Investigating P-glycoprotein expression patterns helps identify potential therapeutic targets in cancer treatment. Current studies focus on understanding how P-glycoprotein contributes to drug resistance in different cancer types. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of P-glycoprotein and its impact on drug resistance mechanisms.